Valuation JHS Svendgaard Laboratories Limited Bombay S.E.
Stocks
532771
INE544H01014
Personal Products
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.580 INR | +3.84% |
|
+2.43% | -23.12% |
Company Valuation: JHS Svendgaard Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 459.8 | 1,288 | 1,334 | 1,006 | 1,266 | 957.1 |
| Change | - | 180.12% | 3.55% | -24.57% | 25.86% | -24.41% |
| Enterprise Value (EV) 1 | 483.2 | 1,128 | 1,315 | 770.7 | 1,216 | 836.5 |
| Change | - | 133.39% | 16.63% | -41.41% | 57.78% | -31.21% |
| P/E | -23.2x | 102x | -32.6x | -6.62x | -8.19x | -4.71x |
| PBR | 0.26x | 0.68x | 0.72x | 0.58x | 0.75x | 0.55x |
| PEG | - | -1x | 0x | -0x | 0.5x | -0.2x |
| Capitalization / Revenue | 0.32x | 1.28x | 1.55x | 0.98x | 1.74x | 1.04x |
| EV / Revenue | 0.34x | 1.12x | 1.52x | 0.75x | 1.67x | 0.91x |
| EV / EBITDA | 10.8x | 18.6x | 93.7x | -67.8x | 95x | -23.5x |
| EV / EBIT | -16.6x | 317x | -28.6x | -11x | -26.8x | -7.69x |
| EV / FCF | -2.87x | -248x | 6.65x | 1.85x | -3.77x | -7.82x |
| FCF Yield | -34.9% | -0.4% | 15% | 54% | -26.5% | -12.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.325 | 0.1952 | -0.63 | -2.34 | -1.973 | -2.374 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,416 | 1,010 | 862.5 | 1,026 | 728.9 | 922.9 |
| EBITDA 1 | 44.8 | 60.48 | 14.03 | -11.37 | 12.8 | -35.67 |
| EBIT 1 | -29.16 | 3.554 | -46.05 | -69.82 | -45.42 | -108.8 |
| Net income 1 | -19.79 | 11.98 | -40.52 | -154.6 | -154.6 | -197.4 |
| Net Debt 1 | 23.4 | -160.3 | -18.37 | -235.3 | -50.11 | -120.6 |
| Reference price 2 | 7.550 | 20.000 | 20.550 | 15.500 | 16.150 | 11.180 |
| Nbr of stocks (in thousands) | 60,900 | 64,400 | 64,900 | 64,900 | 78,397 | 85,604 |
| Announcement Date | 7/17/20 | 9/6/21 | 9/9/22 | 9/5/23 | 8/16/24 | 8/28/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.37x | 2.51x | 11.7x | 4.72% | 36.58B | |
| 22.27x | 1.54x | 9.02x | 2.13% | 11.12B | |
| 10.71x | 1.09x | 6.39x | 6.3% | 3.81B | |
| 18.41x | 3.27x | 12.2x | 2.29% | 2.73B | |
| 23.94x | 0.83x | 9.21x | 1.53% | 1.42B | |
| 15.84x | - | - | 4.9% | 940M | |
| 25.4x | - | - | 3.11% | 810M | |
| Average | 18.85x | 1.85x | 9.71x | 3.57% | 8.2B | |
| Weighted average by Cap. | 16.91x | 2.22x | 10.76x | 4.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- JHS Stock
- 532771 Stock
- Valuation JHS Svendgaard Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
